Skip to main content

Posts

Showing posts with the label mycoplasma pneumoniae

Assessment of #serum #parameters caused by the #outbreak of #mycoplasma pneumoniae #pneumonia in #children after #COVID19

Abstract Mycoplasma pneumonia pneumonia(MPP) is a common respiratory disease that often occurs in children . The purpose of this study was to explore the clinical characteristics of children with mycoplasma pneumoniae pneumonia, the first outbreak after the prevalence of COVID-19 epidemic . Meanwhile, this study also analyzed the predictive value of serum protein indicators and coagulation parameters in the MPP group, as well as the correlation between these indicators. Children with Mycoplasma pneumoniae admitted to the pediatric ward of Chengdu Fifth People’s Hospital from May 2023 to March 2024 were selected. After screening, 411 children who met the research criteria were selected as the study subjects. All of the blood samples were tested for coagulation function , procalcitonin, serum protein and glucose among MPP group and control group. All data were processed for statistical analysis using GraphPad Prism 10.2.3. Comparison of the serum proteins and coagulation function between...

#Mycoplasma pneumoniae #Infections in Hospitalized #Children — #USA, 2018–2024

Summary - What is already known about this topic? -- Mycoplasma pneumoniae is a common cause of community-acquired pneumonia (CAP) in school-aged children . In the United States, M. pneumoniae infection prevalence decreased during the COVID-19 pandemic and remained low through 2023. - What is added by this report? -- The number of hospital discharges of children with M. pneumoniae –associated CAP from U.S. pediatric hospitals increased sharply in 2024, accounting for approximately one half of hospitalized children with CAP. This number included children aged <5 years , a group in which M. pneumoniae infections have historically been less commonly reported. Data on length of hospitalization and intensive care unit admissions indicate that M. pneumoniae infections in 2024 were not more severe than 2018–2023 infections. - What are the implications for public health practice? -- Increased awareness among health care providers might improve diagnosis and could guide treatment of M. pneum...

Increased #Pneumonia-Related #Emergency Department Visits, Northern #Italy

Abstract An increase in pneumonia-related emergency department visits was observed in Lombardy, northern Italy, during June–October 2024. Viral causes appear insufficient to explain the increase, suggesting a bacterial cause . Mycoplasma pneumoniae and Bordetella pertussis emerged as possible causes when other surveillance systems were consulted, but the reasons behind this trend remain unknown . Source: US Centers for Disease Control and Prevention,  https://wwwnc.cdc.gov/eid/article/31/5/24-1790_article ____

#Mycoplasma pneumoniae #infection in #adult inpatients during the 2023–24 #outbreak in #France (MYCADO): a national, retrospective, observational study

Summary Background An epidemic of Mycoplasma pneumoniae infection has been observed in France since September, 2023. We aimed to describe the characteristics of adults hospitalised for M pneumoniae infection and identify factors associated with severe outcomes of infection. Methods MYCADO is a retrospective observational study including adults hospitalised for 24 h or more in 76 hospitals in France for a M pneumoniae infection between Sept 1, 2023, and Feb 29, 2024. Clinical, laboratory, and imaging data were collected from medical records. We identified factors associated with severe outcomes of infection, defined as a composite of intensive care unit (ICU) admission or in-hospital death, using multivariable logistic regression. Findings 1309 patients with M pneumoniae infection were included : 718 (54·9%) were men and 591 (45·1%) were women; median age was 43 years (IQR 31–63); 288 (22·0%) had chronic respiratory failure; 423 (32·3%) had cardiovascular comorbidities; and 105 (8·0%) h...

#China, National sentinel #surveillance of acute #respiratory infectious #diseases (Week 52, 2024)

{Excerpt} In the 52nd week of 2024 ( December 23rd to December 29th ), respiratory samples from outpatient influenza-like cases and hospitalized severe acute respiratory infection cases collected in sentinel hospitals across the country (excluding Hong Kong, Macao and Taiwan) were tested for 10 viruses including the new coronavirus, influenza virus, respiratory syncytial virus, adenovirus, human metapneumovirus, parainfluenza virus, common coronavirus, bocavirus, rhinovirus and enterovirus , as well as multiple respiratory pathogens including Mycoplasma pneumoniae. 1. Test results The pathogens detected positive in respiratory samples of influenza-like cases in outpatient and emergency departments of sentinel hospitals were mainly influenza virus, human metapneumovirus, and rhinovirus ; the pathogens detected positive in respiratory samples of hospitalized severe acute respiratory infection cases were mainly influenza virus, Mycoplasma pneumoniae, and human metapneumovirus . The specif...